Blue Jet Healthcare Limited (BLUEJET)
Healthcare | Biotechnology
₹1010.2
4.07% (₹39.5)
Market Overview
| Market Cap | 175234334720 |
| Volume | 922418 |
| 52W High | ₹1015.0 |
| 52W Low | ₹401.05 |
Key Ratios
| P/E Ratio | 57.463028 |
| EPS | 17.58 |
| Beta | 0 |
| Dividend Yield | 0.11% |
Financial Performance
Revenue Growth
0.851%
Profit Margin
0.29632%
ROE
0.30855%
ROA
0.20504%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: 0.9% revenue growth indicates weak business expansion.
Profitability: 29.6% profit margin shows excellent operational efficiency.
Returns: ROE of 30.9% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 57.5x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹17523.4Cr
- Beta: 0.00 (Market Volatility)
- 52-Week Range: ₹401.1 - ₹1015.0
Last Updated: 2025-07-19 12:01:20